BCRX — BIOCRYST PHARMACEUTICALS INC CMN COM

Ownership history in ALGERT GLOBAL LLC  ·  20 quarters on record

This page tracks every 13F SEC filing in which ALGERT GLOBAL LLC reported a position in BIOCRYST PHARMACEUTICALS INC CMN COM (BCRX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.24% (2010 Q2)
Avg. % of fund
0.1%
First filed
2010 Q2
Last filed
2025 Q3
Quarters held
20
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 REDUCED 713,088 -289,722 -28.9% 0.09% $5.4M $7.59
2025 Q2 ADDED 1,002,810 +42,753 +4.5% 0.19% $9.0M $8.96
2025 Q1 ADDED 960,057 +234,752 +32.4% 0.18% $7.2M $7.50
2024 Q4 ADDED 725,305 +209,096 +40.5% 0.13% $5.5M $7.52
16 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    BCRX price (monthly, adj. close)

Other funds also holding BCRX

As of 2025 Q4 — sorted by position size

Elmind Capital, LP 4.95% Kynam Capital Management, LP 3Y 4.67% DEERFIELD MANAGEMENT COMPANY, L.P. 3Y 7Y 1.43% RA CAPITAL MANAGEMENT, L.P. 3Y 7Y 1.26% SPHERA FUNDS MANAGEMENT LTD. 3Y 7Y 1.26% Eversept Partners, LP 3Y 7Y 1.18% RICE HALL JAMES & ASSOCIATES, LLC 3Y 7Y 0.82% DAFNA Capital Management LLC 3Y 7Y 0.76% Parkman Healthcare Partners LLC 3Y 0.67% Vestal Point Capital, LP 0.6%
← Back to ALGERT GLOBAL LLC Holdings